MMIT (Managed Markets Insight & Technology)’s Post

With the help of AI and more longitudinal patient data, clinical and market access strategies are becoming more patient-centric. https://ow.ly/nZzk50UCe8c Drug Discovery & Development asked MMIT’s Saroja (Kala) Bala and Andrew Rouff to share their thoughts on what 2025 will bring regarding data integration, biosimilar competition, warranty-based contracting, and more. Click the link in this post to read the article. #InflationReductionAct #PatientEngagement #Biosimilars

What will 2025 bring for drug discovery? A convergence of #clinicalresearch and #patient care as well as #dataintegration, validation, and evolving markets. Great piece by Brian K. Buntz Drug Discovery & Development. According to (client) Noga Leviner, CEO of PicnicHealth, who anticipates a convergence of data from clinical research and routine patient care: “In the coming years, the distinction between data collected for clinical research and data collected in real-world clinical practice will blur,” Leviner said. “Researchers will be able to tap into this rich, longitudinal data to gain deep, personalized insights about individual patients.” https://lnkd.in/gd-NqPB2

🌟 Advancing Precision Medicine with Dandelion Health! 🌟 Exciting news from the healthcare technology startup Dandelion Health! They've launched a groundbreaking GLP-1 data library, a comprehensive dataset aimed at driving precision medicine in cardiometabolic disease treatment. Partnering with leading healthcare systems, Dandelion has aggregated structured and unstructured data from over 10 million patients, creating a rich repository of information. This cutting-edge approach will empower researchers, life sciences companies, and healthcare organizations to explore new frontiers in personalized care. Curious about how artificial intelligence and real-world data are transforming medicine? Join us in supporting the advancement of healthcare solutions! 🚀 #PrecisionMedicine #HealthcareInnovation #LifeSciences 🔗 Click the link below to read the full article and discover how Dandelion Health is pushing the boundaries of innovation in healthcare:

Let’s talk about advancements in precision medicine! 🎯 In an interview with pharmaphorum, our VP of Product Management, Jason Gagner MBA, MS discussed how real-world data (RWD) plays a crucial role in generating actionable real-world evidence (RWE) to enhance patient care and treatment outcomes. At #PurpleLab, our HealthNexus platform harmonizes diverse #healthcare data, enabling researchers to identify specific patient cohorts and optimize treatment methodologies. These insights are invaluable for #clinicaltrial design, drug launches, and improving physician education. By leveraging RWD, we can deliver targeted medications to the right patients and drive innovation in the industry. Read the full article to learn more about how RWE platforms are shaping the future of healthcare 👉 https://lnkd.in/eT8nM8ai #PrecisionMedicine #RealWorldData #HealthTech #PatientOutcomes #HealthcareInnovation #HealthData

Lindus Health secures $55M to advance AI technology for clinical trials - MobiHealthNews Lindus Health has raised $55 million in Series B funding to revolutionize clinical trials through AI technology. This anti-CRO offers integrated services and a unique commercial model, promising trials three times faster than traditional methods. With a focus on optimizing study design and automating data monitoring via its Citrus platform, Lindus aims to address inefficiencies in the industry. As co-founder Meri Beckwith states, "Lindus breaks the cycle by completely reinventing the way clinical trials operate." The future of clinical research is here! #HealthcareIT #ClinicalTrials #ArtificialIntelligence #DigitalHealth #Innovation #LifeSciences #CRO ai.mediformatica.com #clinical #trial #research #health #clinicaltrials #lindushealth #study #patients #management #model #seriesb #technology #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4jqAQaK)

🔍 Join Thermo Fisher Scientific (PPD) webinar to explore critical strategies to accelerate clinical trials in today’s fast-evolving research landscape. With 85% of trials facing delays and costs reaching up to $8 million per day, speeding up time-to-market is vital. Topics include: 🚀 How comprehensive CRO and CDMO solutions streamline trial processes and reduce delays 🚀 The role of data and AI in connecting trial progress and patient outcomes 🚀 Managing site burden and optimizing site feasibility to improve efficiency and patient care ➡️ REGISTER HERE: https://buff.ly/3NzvICr #ClinicalTrials #ClinicalResearch #CRO #MachineLearning #ClinicalOperations #ClinicalData #ArtificialIntelligence #AI #Sites #CDMO #CMO #SiteFeasibility

"A staggering 70 percent of sites say clinical trials have become more challenging to manage in the last five years, which has implications in terms of cost and timeline." - Elisa Cascade Clinical research is evolving at an unprecedented pace. With the rise of decentralized trials and the integration of advanced technologies like Agentic AI, the potential to streamline operations and accelerate outcomes has never been greater. "When it comes to the relevant technology, connectivity will prove key to overcoming the expected clinical workforce shortage in 2025." Capture more valuable insights into the latest trends in clinical trials here: https://lnkd.in/eZfqK5tX

On an episode of “Transforming Biopharma,” we discussed the pain points related to #ClinicalTrials, including patient recruitment and retention, as well as trial design. It’s encouraging to read this STAT article profiling six companies that are helping drugmakers streamline their processes to address these and other issues. https://lnkd.in/eZA3hSiH

**🎙️ New Podcast Episode Alert! | Digital Rheumatology Network 🎙️**   Discover the pivotal role of the **US Food and Drug Administration (FDA)** in regulating **Artificial Intelligence (AI)** in healthcare and biomedicine. This episode dives into insights from a g**JAMA article* called: AI IN MEDICINE: FDA Perspective on the Regulation of Artificial Intelligence in HealthCare and Biomedicine by  Haider J. Warraich, MD; Troy Tazbaz, BS; Robert M.Califf, MD exploring: - The **history of FDA regulation** for AI-enabled medical products. - The **opportunities and challenges** of integrating AI into healthcare. - Key concepts for adapting regulatory frameworks to keep pace with rapidly advancing AI technologies. - Applications of AI in **drug development**, **clinical research**, and **patient care**. - Why a **holistic, lifecycle approach** to AI systems is essential for safety and effectiveness. - The importance of **global and cross-industry collaboration** to ensure AI transforms healthcare responsibly. Listen here: https://lnkd.in/e5GFxVZT Thanks to our sponsor AbbVie

🌟 We're excited to unveil the Lifebit Clinical Portal v2 – our all-encompassing solution aimed at transforming patient care through superior data management, the integration of EHR and genomic data, and AI-powered diagnostics and personalized treatments. Key Features of Our Clinical Portal: 📊 Robust Patient Management: Seamlessly integrate patient histories, treatment plans, and ongoing care information. 🔄 Automated Recruitment & Consent Management: Streamline and secure patient consents quickly, accelerating approvals for essential tests and treatments. 🔔 Criteria-Based Notifications: Deploy automated alerts to immediately notify healthcare teams when patients meet specific diagnostic or therapeutic criteria. 📝 Seamless Clinical Note Integration: Ensure all clinical notes are integrated and synchronized within patients’ EHR systems, maintaining a unified and comprehensive health record. 💊 Pharmacogenomic Reporting: Generate tailored pharmacogenomic reports to assist clinicians in treatment and dosage decisions. 🔍 Comprehensive Genomic Data Analysis: Analyze genomic data to identify significant genetic variants that could influence treatment strategies. 🎯 Dynamic Variant Filtering and Therapy Recommendations: Provide precise therapy recommendations, enhancing the clinical decision-making process. The Lifebit Clinical Portal v2 integrates AI and advanced software capabilities with genomic and health data to optimize patient workflows and ensure more efficient & accurate data management. We're empowering healthcare providers worldwide to achieve higher diagnostic accuracy and improve personalized patient care, setting new benchmarks in precision medicine. Learn more about how our platform can meet the complex needs of modern medical institutions in our latest blog: Read more here. #PrecisionMedicine #Genomics #AI #PatientData #Lifebit